Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone-enhanced exposure therapy for social anxiety disorder
2014-004475-23Phase 3Active
- Sponsor
- Radboud University
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of testosterone in Social Anxiety Disorder (SAD) (2 arms), sponsored by Radboud University. Primary endpoint: Reduction in social anxiety disorder symptoms. Started Dec 2014; status: active.
02
Drugs
testosterone
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on 2014-004475-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004475-23.